Operating Margin of Orchestra BioMed Holdings, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary: Orchestra BioMed Holdings, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2022 to 31 Dec 2025.
Orchestra BioMed Holdings, Inc. Operating Margin for the quarter ending 31 Dec 2025 was -155%, a 94% increase year-over-year.
Orchestra BioMed Holdings, Inc. annual Operating Margin for 2025 was -155%, a 94% increase from 2024.
Orchestra BioMed Holdings, Inc. annual Operating Margin for 2024 was -2437%, a 31% decline from 2023.
Orchestra BioMed Holdings, Inc. annual Operating Margin for 2023 was -1866%, a 102% decline from 2022.

Operating Margin, Quarterly (%)

Operating Margin, YoY Quarterly Change (%)

Operating Margin, Annual (%)

Operating Margin, YoY Annual Change (%)

Orchestra BioMed Holdings, Inc. Quarterly Operating Margin (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q4 2025	-155%	+2283%	+94%	01 Oct 2025	31 Dec 2025
Q3 2025	-2670%	-399%	-18%	01 Jul 2025	30 Sep 2025
Q2 2025	-2421%	+383%	+14%	01 Apr 2025	30 Jun 2025
Q1 2025	-2384%	+70%	+2.9%	01 Jan 2025	31 Mar 2025
Q4 2024	-2437%	-571%	-31%	01 Oct 2024	31 Dec 2024
Q3 2024	-2271%	-914%	-67%	01 Jul 2024	30 Sep 2024
Q2 2024	-2804%	-1782%	-174%	01 Apr 2024	30 Jun 2024
Q1 2024	-2454%	-1434%	-141%	01 Jan 2024	31 Mar 2024
Q4 2023	-1866%	-942%	-102%	01 Oct 2023	31 Dec 2023
Q3 2023	-1357%			01 Jul 2023	30 Sep 2023
Q2 2023	-1022%			01 Apr 2023	30 Jun 2023
Q1 2023	-1020%			01 Jan 2023	31 Mar 2023
Q4 2022	-924%			01 Oct 2022	31 Dec 2022

Period	Value	YoY Chg	Change %	Start Date	End Date
2025	-155%	+2283%	+94%	01 Jan 2025	31 Dec 2025
2024	-2437%	-571%	-31%	01 Jan 2024	31 Dec 2024
2023	-1866%	-942%	-102%	01 Jan 2023	31 Dec 2023
2022	-924%			01 Jan 2022	31 Dec 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.